Screening for asymptomatic mpox in at-risk populations: A cross-sectional study

Inés Armenteros Yeguas(Universidad Complutense de Madrid), Vicente Estrada(Instituto de Salud Carlos III), Eva Orviz(Hospital Clínico San Carlos), Montserrat Torres(Centre international de recherche sur le cancer), Teresa Puerta(Hospital Clínico San Carlos), Adrián Valls Carbó(Hospital Clínico San Carlos), Mar Vera(Hospital Clínico San Carlos), Oskar Ayerdi(Hospital Clínico San Carlos), Pérez García J(Hospital Clínico San Carlos), Reynaldo Homen(Instituto de Salud Carlos III), Laura Dans(Hospital Clínico San Carlos), Mayte Coiras(Instituto de Salud Carlos III)
PLoS ONE
October 30, 2025
10.1371/journal.pone.0335729
Cited by 1

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
|The Lancet|2006|343
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
|Mucosal Immunology|2014|332